Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190